SELECT MEDICAL HOLDINGS CORP (SEM) Stock Analyst Earnings Estimates
NYSE:SEM - New York Stock Exchange, Inc. - US81619Q1058 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.609B -25.71% | 4.826B 4.70% | 5.187B 7.48% | 5.46B 5.26% | 5.749B 5.29% | 6.041B 5.08% | |
| EBITDA YoY % growth | 350.579M -61.74% | 475.984M 35.77% | 472.209M -0.79% | 522.94M 10.74% | 562.5M 7.56% | 608.46M 8.17% | |
| EBIT YoY % growth | 144.754M -79.72% | 267.242M 84.62% | 268.315M 0.40% | 370.8M 38.20% | 397.17M 7.11% | 449.01M 13.05% | |
| Operating Margin | 3.14% | 5.54% | 5.17% | 6.79% | 6.91% | 7.43% | |
| EPS YoY % growth | 1.23 -58.72% | 1.99 61.79% | 1.65 -17.09% | 1.11 -32.46% | 1.30 17.07% | 1.58 21.29% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.16 -63.36% | 0.26 303.55% | 0.44 1.00% | 0.29 -8.47% | 0.22 37.82% | 0.30 12.60% | 0.56 25.00% | 0.32 10.34% | 0.22 2.33% | 0.34 15.25% |
| Revenue Q2Q % growth | 1.344B -23.69% | 1.39B 5.90% | 1.432B 5.83% | 1.45B 8.24% | 1.434B 6.70% | 1.492B 7.34% | 1.614B 12.71% | 1.577B 8.76% | 1.544B 7.67% | 1.593B 6.77% |
| EBITDA Q2Q % growth | 111.54M -62.73% | 132M -11.86% | 160.67M 8.89% | 141.87M -9.17% | 125.98M 12.95% | 147.41M 11.67% | 194.54M 21.08% | 156.92M 10.61% | 136.51M 8.36% | 158.48M 7.51% |
| EBIT Q2Q % growth | 74.882M -46.94% | 91.223M -2.00% | 122.39M 8.55% | 97.859M 13.09% | 82.372M 10.00% | 102.24M 12.08% | 144.49M 18.06% | 108.03M 10.39% | 88.648M 7.62% | 109.1M 6.71% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.32 -46.67% | 0.25 | 0.07 | 30.21% |
| Q1 2025 Q2Q % growth | 0.44 -41.33% | 0.46 | -0.02 | -4.04% |
| Q4 2024 Q2Q % growth | -0.13 -136.11% | 0.22 | -0.35 | -158.51% |
| Q3 2024 Q2Q % growth | 0.43 -6.52% | 0.44 | -0.01 | -1.75% |
| Q2 2024 Q2Q % growth | 0.60 -1.64% | 0.61 | -0.01 | -2.08% |
| Q1 2024 Q2Q % growth | 0.75 33.93% | 0.58 | 0.17 | 29.14% |
| Q4 2023 Q2Q % growth | 0.36 63.64% | 0.36 | 0.00 | 0.40% |
| Q3 2023 Q2Q % growth | 0.46 119.05% | 0.41 | 0.05 | 11.77% |
| Q2 2023 Q2Q % growth | 0.61 41.86% | 0.48 | 0.13 | 26.14% |
| Q1 2023 Q2Q % growth | 0.56 51.35% | 0.44 | 0.12 | 26.82% |
| Q4 2022 Q2Q % growth | 0.22 -40.54% | 0.36 | -0.14 | -39.39% |
| Q3 2022 Q2Q % growth | 0.21 -63.16% | 0.46 | -0.25 | -54.20% |
| Q2 2022 Q2Q % growth | 0.43 -64.75% | 0.56 | -0.13 | -22.98% |
| Q1 2022 Q2Q % growth | 0.37 -54.88% | 0.28 | 0.09 | 33.02% |
| Q4 2021 Q2Q % growth | 0.37 -35.09% | 0.31 | 0.06 | 19.87% |
| Q3 2021 Q2Q % growth | 0.57 1.79% | 0.53 | 0.04 | 7.83% |
| Q2 2021 Q2Q % growth | 1.22 221.05% | 0.56 | 0.66 | 116.16% |
| Q1 2021 Q2Q % growth | 0.82 121.62% | 0.61 | 0.21 | 34.02% |
| Q4 2020 Q2Q % growth | 0.57 83.87% | 0.31 | 0.26 | 83.83% |
| Q3 2020 Q2Q % growth | 0.56 69.70% | 0.29 | 0.27 | 90.14% |
| Q2 2020 Q2Q % growth | 0.38 15.15% | 0.02 | 0.36 | 2,087.43% |
| Q1 2020 Q2Q % growth | 0.37 37.04% | 0.32 | 0.05 | 15.93% |
| Q4 2019 Q2Q % growth | 0.31 | 0.19 | 0.12 | 63.64% |
| Q3 2019 Q2Q % growth | 0.33 | 0.21 | 0.12 | 57.65% |
| Q2 2019 Q2Q % growth | 0.33 | 0.33 | 0.00 | -0.99% |
| Q1 2019 Q2Q % growth | 0.27 | 0.28 | -0.01 | -2.49% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.34B -23.87% | 1.357B | -17.421M | -1.28% |
| Q1 2025 Q2Q % growth | 1.353B -24.35% | 1.404B | -50.828M | -3.62% |
| Q4 2024 Q2Q % growth | 1.313B -20.88% | 1.476B | -163.436M | -11.07% |
| Q3 2024 Q2Q % growth | 1.761B 5.73% | 1.754B | 7.22M | 0.41% |
| Q2 2024 Q2Q % growth | 1.76B 5.08% | 1.762B | -2.337M | -0.13% |
| Q1 2024 Q2Q % growth | 1.789B 7.44% | 1.756B | 32.809M | 1.87% |
| Q4 2023 Q2Q % growth | 1.659B 4.89% | 1.656B | 2.856M | 0.17% |
| Q3 2023 Q2Q % growth | 1.666B 6.24% | 1.643B | 22.694M | 1.38% |
| Q2 2023 Q2Q % growth | 1.675B -47.41% | 1.659B | 15.528M | 0.94% |
| Q1 2023 Q2Q % growth | 1.665B 4.09% | 1.662B | 2.98M | 0.18% |
| Q4 2022 Q2Q % growth | 1.581B 1.39% | 1.6B | -18.544M | -1.16% |
| Q3 2022 Q2Q % growth | 1.568B 2.19% | 1.575B | -7.206M | -0.46% |
| Q2 2022 Q2Q % growth | 3.184B 2.37% | 1.598B | 1.586B | 99.27% |
| Q1 2022 Q2Q % growth | 1.6B 3.43% | 1.577B | 22.547M | 1.43% |
| Q4 2021 Q2Q % growth | 1.56B 6.80% | 1.537B | 22.811M | 1.48% |
| Q3 2021 Q2Q % growth | 1.534B 7.75% | 1.458B | 76.221M | 5.23% |
| Q2 2021 Q2Q % growth | 3.11B 152.33% | 1.451B | 1.659B | 114.37% |
| Q1 2021 Q2Q % growth | 1.547B 9.32% | 1.457B | 89.5M | 6.14% |
| Q4 2020 Q2Q % growth | 1.461B 6.25% | 1.425B | 35.5M | 2.49% |
| Q3 2020 Q2Q % growth | 1.424B 2.20% | 1.38B | 43.9M | 3.18% |
| Q2 2020 Q2Q % growth | 1.233B -9.45% | 1.166B | 66.7M | 5.72% |
| Q1 2020 Q2Q % growth | 1.415B 6.79% | 1.381B | 33.6M | 2.43% |
| Q4 2019 Q2Q % growth | 1.375B | 1.349B | 25.6M | 1.90% |
| Q3 2019 Q2Q % growth | 1.393B | 1.327B | 66.3M | 5.00% |
| Q2 2019 Q2Q % growth | 1.361B | 1.36B | 1.4M | 0.10% |
| Q1 2019 Q2Q % growth | 1.325B | 1.341B | -16.4M | -1.22% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.45% | -43.88% | 0% | -0.42% |
| Revenue | 0% | -0.67% | 0% | -0.15% |